BCRG biomedical centre was established in 2015 as a joint project of the Medical Faculty, University of Ostrava and the Hematooncology Department, University Hospital Ostrava. BCRG teams focus on both basic and pre-clinical research with the main aim to develop novel therapeutical approaches in the field of monoclonal gammopathies and other haematological disorders.

Current Events

Latest News

Deputy Head of the Department of Hemato-Oncology doc. MUDr. Tomáš Jelínek Ph.D. has been awarded the prestigious EHA Physician Scientist Research Grant 2025
June 30, 2025

He received this honor from the European Hematology Association (EHA), and the grant will support his scientific research in the field of hematology for a period of 3 years. “It is a great honor for me to receive such an award. This grant will allow…

University Hospital Ostrava Awarded G-Rex® Grant to Support CAR-T and CAR-NK Therapy Development
June 16, 2025

Our colleague, MUDr. Mgr. Sandra Charvátová, Ph.D., has been awarded a G-Rex grant to support the development of new cancer immunotherapies. Thanks to this grant, we will be able to use innovative technology for the efficient production of cells that…

Open positions for Ph.D. students and Postdoc researchers
June 16, 2025

Employer: Blood Cancer Research Group, Faculty of Medicine, University of Ostrava, Czech Republic The Immuno-Biophysics Lab within the Blood Cancer Research Group (BCRG) at the Faculty of Medicine, University of Ostrava, is currently seeking…

Latest Publications

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma

Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group

Scroll to Top